Literature DB >> 24332805

Quantitative neuroimaging in mucolipidosis type IV.

Raphael Schiffmann1, Joan Mayfield2, Caren Swift3, Igor Nestrasil4.   

Abstract

Mucolipidosis type IV (MLIV) is an autosomal recessive disorder resulting from mutations in the MCOLN1 gene. This gene encodes the endosomal/lysosomal transient receptor potential channel protein mucolipin-1 (TRPML1). Affected patients suffer from neurodevelopmental abnormalities and progressive retinal dystrophy. In a prospective natural history study we hypothesized the presence of an additional slow cerebral neurodegenerative process. We have recruited 5 patients, tested their neurodevelopmental status, and measured cerebral regional volumes and white matter integrity using MRI yearly. Over a period of up to 3 years, MLIV patients remained neurologically stable. There was a trend for increased cortical and subcortical gray matter volumes and increased ventricular size, while white matter and cerebellar volumes decreased. Mean diffusivity (MD) was increased and fractional anisotropy (FA) values were below normal in all analyzed brain regions. There was a positive correlation between motor scores of the Vineland Scale and the FA values in the corticospinal tract (corr coef 0.39), and a negative correlation with the MD values (corr coef -0.50) in the same brain region. We conclude from these initial findings that deficiency in mucolipin-1 affects the entire brain but that there might be a selective regional cerebral neurodegenerative process in MLIV. In addition, these data suggest that diffusion-weighted imaging might be a good biomarker for following patients with MLIV. Therefore, our findings may be helpful for designing future clinical trials.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lysosomal disorder; Mucolipidosis; Natural history; Volumetry

Mesh:

Year:  2013        PMID: 24332805      PMCID: PMC4097300          DOI: 10.1016/j.ymgme.2013.11.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  27 in total

1.  Characterization and propagation of uncertainty in diffusion-weighted MR imaging.

Authors:  T E J Behrens; M W Woolrich; M Jenkinson; H Johansen-Berg; R G Nunes; S Clare; P M Matthews; J M Brady; S M Smith
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

2.  Ventricular volume change in childhood.

Authors:  Chris Xenos; Spyros Sgouros; Kalyan Natarajan
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

3.  Constitutive achlorhydria in mucolipidosis type IV.

Authors:  R Schiffmann; N K Dwyer; I A Lubensky; M Tsokos; V E Sutliff; J S Latimer; K P Frei; R O Brady; N W Barton; E J Blanchette-Mackie; E Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 4.  Mucolipidosis IV: morphology and histochemistry of an autopsy case.

Authors:  R D Folkerth; J Alroy; I Lomakina; E Skutelsky; S S Raghavan; E H Kolodny
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

5.  Mucolipidosis type IV: characteristic MRI findings.

Authors:  K P Frei; N J Patronas; K E Crutchfield; G Altarescu; R Schiffmann
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

6.  Mucolipidosis type IV: clinical manifestations and natural history.

Authors:  D Chitayat; C M Meunier; K A Hodgkinson; K Silver; M Flanders; I J Anderson; J M Little; D A Whiteman; S Carpenter
Journal:  Am J Med Genet       Date:  1991-12-01

7.  Diffuse neuroaxonal involvement in mucolipidosis IV as assessed by proton magnetic resonance spectroscopic imaging.

Authors:  Simona Bonavita; Anette Virta; Neal Jeffries; Ehud Goldin; Gioacchino Tedeschi; Raphael Schiffmann
Journal:  J Child Neurol       Date:  2003-07       Impact factor: 1.987

8.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

9.  Mucolipidosis type IV: clinical spectrum and natural history.

Authors:  N Amir; J Zlotogora; G Bach
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

10.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging.

Authors:  Rachael I Scahill; Chris Frost; Rhian Jenkins; Jennifer L Whitwell; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2003-07
View more
  16 in total

1.  A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.

Authors:  Marisol Mirabelli-Badenier; Mariasavina Severino; Barbara Tappino; Domenico Tortora; Francesca Camia; Clelia Zanaboni; Fabia Brera; Enrico Priolo; Andrea Rossi; Roberta Biancheri; Maja Di Rocco; Mirella Filocamo
Journal:  Metab Brain Dis       Date:  2014-08-26       Impact factor: 3.584

2.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

3.  Cognitive Development in a Young Child with Mucolipidosis Type IV: A Case Report.

Authors:  Evelyn L Fisher; Rose A Sevcik; MaryAnn Romski
Journal:  JIMD Rep       Date:  2017-01-03

4.  White Matter Microstructure and Subcortical Gray Matter Structure Volumes in Aspartylglucosaminuria; a 5-Year Follow-up Brain MRI Study of an Adolescent with Aspartylglucosaminuria and His Healthy Twin Brother.

Authors:  Tokola Anna; Brandstack Nina; Hakkarainen Antti; Salli Eero; Åberg Laura; Autti Taina
Journal:  JIMD Rep       Date:  2017-02-10

Review 5.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

6.  Acidic Ca2+ stores in neurodegeneration.

Authors:  Emyr Lloyd-Evans
Journal:  Messenger (Los Angel)       Date:  2016-06-01

7.  White matter abnormalities and iron deposition in prenatal mucolipidosis IV- fetal imaging and pathology.

Authors:  Ayelet Zerem; Liat Ben-Sira; Nitzan Vigdorovich; Zvi Leibovitz; Yael Fisher; Raphael Schiffmann; Yulia Grishchuk; Albert L Misko; Naama Orenstein; Dorit Lev; Tally Lerman-Sagie; Debora Kidron
Journal:  Metab Brain Dis       Date:  2021-05-08       Impact factor: 3.584

8.  Progress in elucidating pathophysiology of mucolipidosis IV.

Authors:  Albert Misko; Levi Wood; Kirill Kiselyov; Susan Slaugenhaupt; Yulia Grishchuk
Journal:  Neurosci Lett       Date:  2021-05-11       Impact factor: 3.197

9.  Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV.

Authors:  Yulia Grishchuk; Karina A Peña; Jessica Coblentz; Victoria E King; Daniel M Humphrey; Shirley L Wang; Kirill I Kiselyov; Susan A Slaugenhaupt
Journal:  Dis Model Mech       Date:  2015-09-17       Impact factor: 5.758

10.  Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV.

Authors:  Yulia Grishchuk; Sarmi Sri; Nikita Rudinskiy; Weiyuan Ma; Katherine G Stember; Matthew W Cottle; Ellen Sapp; Marian Difiglia; Alona Muzikansky; Rebecca A Betensky; Andrew M S Wong; Brian J Bacskai; Bradley T Hyman; Raymond J Kelleher; Jonathan D Cooper; Susan A Slaugenhaupt
Journal:  Acta Neuropathol Commun       Date:  2014-09-09       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.